Sunbird Bio (Singapore Subsidiary) is VC-Backed and has raised funding across Venture - General / Other and Merger - Glympse Bio rounds. It is backed by Sunbird Bio and ClavystBio.
Alternatives.pe tracks Sunbird Bio (Singapore Subsidiary)'s funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Browse all uploaded documents here
Extracted Financial Statement 2024
Extracted Financial Statement
ViewExtracted Financial Statement 2022
Extracted Financial Statement
ViewExplore the latest updates and insights
Sunbird Bio announced the closing of a USD 14M financing round, backed by two new investors, Eli ... see summary
Sunbird Bio acquires Glympse Bio to enhance Alzheimer's diagnostics
A view of the number of employees over time
Extracted Financial Statement 2021
Extracted Financial Statement
ViewAcquisition event
Sunbird Bio Merges with Glympse Bio to Accelerate Development of Proprietary Protein-Based Diagnostic Technologies
Key members of the management team